Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy

Date
2007
Author
Besisik, Fatih
Cakaloglu, Yilmaz
Demir, Kadir
Akyuz, Filiz
Okten, Atilla
Aksoy, Nevzat
Karaca, Cetin
Danalioglu, Ahmet
Onel, Derya
Badur, Selim
Kaymakoglu, Sabahattin
Metadata
Show full item record
Abstract
Background and study aims : To investigate the efficacy of the combined therapy of lamivudine (LAM) plus alpha interferon (IFN) and LAM monotherapy in HBeAg negative chronic hepatitis B (CHB) patients who were unresponsive to previous IFN monotherapy, and the incidence of YMDD mutations.
URI
http://hdl.handle.net/20.500.12627/155448
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34247105858&origin=inward
Collections